Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2674 of 5804
-
Fasting may soothe aromatase inhibitor side effects
Symptom relief CompletedIn this explorative study, the feasibility of therapeutic fasting to reduce limitations in physical well-being and quality of life of patients undergoing endocrine therapy with aromatase inhibitors will be investigated. In addition, the application of the StudyU app, which is cur…
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy shows promise for stroke balance recovery
Symptom relief CompletedThe aim of the study is to examine the impact of motor imagery, Erigo®Pro tilt table intervention, and classic rehabilitation on the balance of people after a stroke.
Phase: NA • Sponsor: Anna Olczak • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New jaw therapy targets the Brain's emotion center to ease pain
Symptom relief CompletedTemporomandibular joint disorders (TMD) are common conditions that may cause jaw pain, limited jaw movement, and reduced quality of life. Individuals with TMD can also experience neck-related problems, balance impairments, emotional changes, and sleep disturbances. This interven…
Phase: NA • Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Personalized immune monitoring could transform liver transplant care
Knowledge-focused OngoingTo develop a prospective quantitative liver allograft monitoring protocol and retrospectively validate the use of Phenotypic personalized medicine (PPM) in immunosuppression dosing in liver transplant recipients.
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Remote training and tiny sensors could revolutionize low vision care
Symptom relief Recruiting nowOne goal of this research is to conduct a non-inferiority trial of telerehabilitation versus in-office care to provide follow-up training to individuals with low vision to enhance their quality of life by using magnification devices and/or visual assistive mobile apps for importa…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Could a simple supplement protect your gut during radiation?
Symptom relief Recruiting nowThe purpose of this study is to assess and compare GI toxicity from RT between subjects who receive therapeutic SCFA and those who receive placebo, in hopes of identifying a safe, low-cost therapeutic to reduce GI toxicity from therapeutic or environmental radiation.
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can video coaching boost jaw exercise results for teeth grinders?
Symptom relief CompletedThis study looked at whether jaw exercises (the Rocabado exercise programme) work better when delivered through supervised online video sessions than when done at home with written instructions alone, in adults who have jaw-joint pain (temporomandibular disorder) together with te…
Phase: NA • Sponsor: Mehmet Turgut • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Can better hearing ease dementia symptoms? new study says maybe
Symptom relief CompletedBuilding upon the HEARS audiologist-community health worker (CHW) model, this study intervention will be delivered by a speech-language pathologist (SLP). The primary objective of the study is to develop and test an affordable and accessible hearing rehabilitative intervention th…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New antibody drug targets Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to determine safety and recommended phase 2 dose(s) (RP2Ds) of JNJ-87890387 and to determine the safety of JNJ-87890387 at the RP2D(s).
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Mind over movement: new therapy may help Parkinson's patients regain balance
Symptom relief Recruiting nowIn recent years, motor imagery (MI) and action observation (AO) therapy strategies have been used in rehabilitation programs to increase motor learning in Parkinson's disease (PD). Visuomotor training strategies such as AO and MI therapy rely on the activity of the mirror neuron …
Phase: NA • Sponsor: Karamanoğlu Mehmetbey University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Acupuncture and yoga may help seniors taper off benzodiazepines
Symptom relief CompletedThe main purpose of this 12-week study is to see if a new combination of treatments can help older adults reduce benzodiazepine or related medication use. The treatment combination consists of 1) medical provider visits to gradually reduce the medication dose over 12 weeks, 2) ac…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New walking program aims to ease osteoarthritis pain with smart drug timing
Symptom relief Recruiting nowThere is a lack of effective analgesic treatments to help walking patients with painful hip/knee osteoarthritis. Our team therefore imagined a new strategy lying on a multimodal rehabilitation walking program with the help of a transient intake of nonsteroidal anti-inflammatory d…
Phase: PHASE4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Smart cycling could boost immunity and quality of life for COPD patients
Disease control Recruiting nowThe goal of this study is to design eccentric exercise strategies for COPD patients to comprehensively improve their cardiopulmonary/muscular fitness, immune and hemorheological functions, and quality of life, thereby improving the prognosis of their disease.
Phase: NA • Sponsor: Fu Jen Catholic University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a simple supplement ease bipolar depression? new trial tests magnesium B6
Symptom relief Recruiting nowThis is a randomized, double-blind, placebo-controlled proof-of-concept clinical trial to assess the efficacy and safety of Magnesium-vitamin B6in combination with treatment as usual for treating symptoms of depression, stress, and anxiety in patients with first episode bipolar I…
Phase: PHASE2 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Ovarian cancer gene hunt: 300 patients to shape future therapies
Knowledge-focused Recruiting nowDespite recent progress in chemotherapy and targeted therapy for ovarian cancer, the 5-year survival rate remains around 40% because of rapid development of treatment resistance and recurrence. The sensitivity to platinum agents or BRCA genes mutation has been the prerequisite fo…
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
Knowledge-focused OngoingMore than 40% of young adults with type 1 diabetes (T1D) also have overweight or obesity. Each of these diagnoses increase the risk of adverse cardiovascular events. Investigators aim to obtain reference data for individuals with T1D who do not have overweight obesity, to underst…
Phase: PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Old arthritis drug takes on tough cancers in early trial
Disease control Recruiting nowLeflunomide in patients with PTEN-Altered advanced solid tumors or HER2 negative breast cancer. Phase 1A objectives are to determine the safety, tolerability, and the MTD of leflunomide in patients with PTEN-Altered advanced solid malignancies and HER2 negative breast cancer. Pha…
Phase: PHASE1 • Sponsor: Deborah Doroshow • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to spot hidden heart danger in genetic AFib patients
Knowledge-focused Recruiting nowThe goal of this observational study is to determine if electrophysiologic mapping and cardiac MRI can help identify patients that have genetic forms of cardiomyopathy that are at high risk for development of dangerous ventricular arrhythmias. The investigators aim to study: 1.…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Schizophrenia protein may flag hidden heart risk
Knowledge-focused OngoingTo study the association between DISC1 RNA expression levels and cardiac function in patients with schizophrenia.
Sponsor: Norwegian University of Science and Technology • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Magnets may offer a new way to boost weight loss after failed surgery
Disease control CompletedThe objectives of this study are to assess the initial safety and device functionality of the SFM Anastomosis System including delivery systems when used to create a duodenal-ileal (D-I) anastomosis with patients with prior sleeve gastrectomy who experience inadequate weight loss…
Phase: NA • Sponsor: GI Windows, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC